🇺🇸 FDA
Patent

US 10004699

Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse

granted A61KA61K31/137A61K47/10

Quick answer

US patent 10004699 (Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse) held by Acurx Pharmaceuticals, Inc. expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Acurx Pharmaceuticals, Inc.
Grant date
Tue Jun 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/137, A61K47/10, A61K47/12, A61K47/14